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INTRODUCTION
Sundowning describes an array of neuropsychiatric
symptoms and is a common occurrence among
individuals with dementia. The highest prevalence
occurs in community-dwelling and institutionalized
older adults (Canevelli et al., 2016; Gnanasekaran,
2015). During sundowning, symptoms such as
confusion, agitation, and aggression typically
emerge in the late afternoon when light exposure
is diminished (Canevelli et al., 2016). A higher
incidence of sundowning has been reported in
individuals with advanced stages of dementia, as
well as during the winter months when there is less
sunlight (Canevelli et al., 2016). It is believed that
sundowning hastens the progression of cognitive
impairment and increases the rates of
hospitalization, institutionalization, and caregiver
burnout (Canevelli et al., 2016).
Sundowning has been recognized by medical
professionals for over 70 years; yet, it is not
included in the Diagnostic and Statistical Manual of
Mental Disorders (DSM–5) (Gnanasekaran, 2015).
Presently, there are no established guidelines for
the management of symptoms associated with
sundowning syndrome. Although pharmacological
interventions have been used for treatment of
sundowning, their effectiveness is limited and the
risk of interacting with other medications is high
(Gnanasekaran, 2015).
Non-pharmacological interventions, such as
environmental modifications, have emerged as
safer alternatives to medication; however, their
efficacy is still unknown (Gnanasekaran, 2015).
One of these emerging alternatives to traditional
treatment is light therapy (Gnanasekaran, 2015).
The effects of light therapy on sundowning have
not been widely studied. Nevertheless, the limited
research available has suggested its potential to
improve symptoms (Gnanasekaran, 2015). This
systematic review seeks to answer the question: is
light therapy an effective intervention for

sundowning symptoms experienced by individuals
who have dementia?
TEXT BOX 1
Dementia: Overarching term that describes
a group of symptoms related to cognitive
impairment, a decline in memory, and
decreased functioning.
Sundowning: Overarching term for
neuropsychiatric symptoms (e.g. agitation,
aggression, and confusion) that emerges in
individuals with dementia due to lack of
exposure to light (Canevelli et al., 2016).
Pharmacological: Medications and drugs
used to treat illness.
Non-pharmacological: Alternative therapies
to medications and drugs.
Light therapy: The treatment of medical or
psychiatric conditions by the controlled
application of light.

METHODS
A protocol was developed prior to conducting a
comprehensive systematic review (Appendix A).
The protocol is a step-by-step procedure to identify
and appraise all relevant studies.
Identification of Relevant Studies:
A comprehensive and systematic search for
relevant studies was conducted in February and
March of 2019, using the following databases:
PsychINFO, OT Search, OT Seeker, CINAHL,

Health & Medical Complete, Cochrane, and
PubMed. The inclusion and exclusion criteria
included: (1) quantitative study (2) published in
English and (3) peer-reviewed. The search terms
used, keyword combinations, and subject headings
relative to each database can be found in the
protocol (Table 3).
To be included in the systematic review, studies
retrieved during the search met the following
criteria: (1) population with a diagnosis of
dementia, (2) light therapy used as the primary
means of intervention, (3) the outcome measured
at least one of three predetermined characteristics
of sundowning (agitation, confusion, and
aggression). Studies whose population had
comorbid conditions causing memory loss (e.g.
traumatic brain injuries or seizures) were excluded.
Also excluded were articles that discussed other
forms of light therapy not as defined in Text Box 1
(e.g. color therapy, heliotherapy, wave therapy,
etc.). A complete list of inclusion and exclusion
criteria was established in the protocol (Table 5).
A group of six reviewers and six research
assistants independently assessed articles
retrieved from the selected databases using the
predetermined inclusion and exclusion criteria. The
title and abstract of each study were screened by
two reviewers to determine article eligibility. When
a determination from these sections alone could
not be reached, the full article was assessed.
Following independent assessment, the two
assigned reviewers compared their findings of
each article and discussed and resolved any
discrepancies until a consensus was reached.
When necessary, a third reviewer was utilized to
assist with resolving discrepancies between the
two assigned reviewers. All the articles included or
excluded were summarized in a flowchart (Figure
1).
Appraisal of Included Studies:
After all inclusion and exclusion criteria were
applied and the authors came to a consensus
there were 16 articles (Figure 1). In compliance
with the protocol, two independent reviewers
appraised each article to determine the quality of
evidence (Text Box 2) by using predetermined,
study design-specific criteria. Each pair of
reviewers compared individual ratings of the quality
of evidence for each study (Table 6).
Discrepancies between reviewers were resolved
through discussion until a consensus was reached.

A third party reviewer was consulted when an
agreement could not be agreed upon.
Collaboratively, the two reviewers compiled
recorded findings into a descriptive table detailing
nine categories: design type, quality of evidence,
study population, intervention and sample size,
outcomes, measurement tools, point estimate,
clinical significance, and statistical significance
(Table 7). Relevant statistical terminology is
defined in Text Box 2. In cases with no reported
clinical significance, a manual calculation of the
minimally detectable difference (MDD) was
performed when possible. Practice
recommendations and clinical implications were
generated from findings.

TEXT BOX 2:
Statistical Significance: A term indicating
that the results of a study are unlikely to be
the result of chance. (Portney & Watkins,
2009)
Level of Evidence: A ranking system used to
show the strength of a study based on
predetermined criteria.
Quality of Evidence: the degree to which
the study being analyzed is deemed reliable.
Point Estimate: numerical data presented as
mean scores with standard deviations.
Minimally Detectable Differences (MDD):
the smallest amount of change that can be
detected to reflect the true difference.
(Portney & Watkins, 2009)
Minimally Clinically Important Difference
(MCID): the smallest difference detected that
the patient perceives to be beneficial.
(Portney & Watkins, 2009)
Effect Size: An expression that represents
RESULTS
magnitude of the difference between two
treatments or the magnitude of a relationship
The
database
searches (Portney
retrieved &
a Watkins,
total of 701
between
to variables.
2009)
articles. There were 16 articles that met preestablished inclusion criteria and were
Clinical significance:
Whether
the change
subsequently
reviewed. The
flowchart
provides a
observed in a study is large enough to make
detailed breakdown of the study identification
a difference in the patient’s quality of life or is
process
(Figure
1). patient.
detectable
by the

Of the analyzed studies, seven of the studies
followed a quasi-experimental study design,
involving the application of the intervention without
random assignment of participants to conditions or
orders of conditions. Two studies were single case
research designs, where participants serve as their
own control while also receiving the intervention. In
this case, repeated measures are recorded at
multiple phases: baseline, intervention, and followup or withdrawal. Seven studies were randomized
control trials (RCTs), in which group allocation
(control or intervention) was determined through a
process of randomization. RCTs are considered
level I evidence, one of the highest levels of
evidence in intervention studies.
The level of evidence of the studies analyzed in
this systematic review ranged from level I to IV with
levels I and III being the most frequently
represented. The quality of individual studies
ranged from low to high and can be found on the
quality of evidence table (Table 6). A total of 11
studies ranged from moderate to high-quality
evidence, while five were found to be of low quality
(Table 6). Four studies presented with high quality,
meeting 70% or more of design specific criteria
and seven studies presented with moderate quality
ranging from 40% to 70% of criteria being met.
Five articles were low quality, meeting less than
40% of design specific criteria (Table 6). The
included studies measured at least one of three
identified outcomes related to sundowning: (1)
agitation, (2) aggression or (3) confusion.
Agitation
Of the 16 included studies, 15 evaluated the
efficacy of light therapy when utilized as an
intervention to treat agitation. In regards to level of
evidence, five of these studies provided level I
evidence, four provided level III, and four provided
level IV (Table 6). The quality of evidence ranged
from low to high. Four studies presented with low
quality, six with moderate quality, and three with
high quality (Table 6).
There were 10 outcome measures utilized to
evaluate agitation across the 15 identified studies;
with some studies utilizing more than one outcome

measure to estimate agitation (Table 8). There
were 10 studies that utilized six of the identified
outcome measures and found light therapy to be
effective in treating agitation (p<0.05; Table 8).
Three studies, through three outcome measures,
found no statistical significance and two studies
which utilized the outcome measures of
observation and the Confusion Rating Scale (CRS)
did not provide information regarding statistical
significance (Table 8).
In regards to clinical significance, 11 studies using
eight outcome measures found no clinical
significance when utilizing light therapy as an
intervention to decrease agitation (Table 8). Two
studies, which both utilized the Cohen-Mansfield
Agitation Inventory (CMAI) as an outcome
measure, found light therapy to be a clinically
significant intervention and two studies did not
provide information regarding clinical significance
nor provide sufficient data for significance to be
calculated by reviewers (Table 8).
Aggression
Five of the studies included in the systematic
review evaluated the efficacy of light therapy for
treating aggression. Two of these studies provided
level I evidence, with one being high-quality
evidence and one being low-quality evidence
(Table 8). The remaining three studies provided
low-quality, level III evidence (Table 8). There were
six outcome measures utilized across the five
identified studies which measured agitation (Table
8). Three studies, using four of the identified
outcome measures among them, found light
therapy to be effective in decreasing aggression
(p<0.05; Table 8). One study, which utilized both
the Gedragsobservatieschaal voor Intramurale
Psychogeriatrie (GIP) and the Social Dysfunction
and Aggression Scale (SDAS-9) as outcome
measures for aggression, found mixed results in
regard to statistical significance and one study did
not provide information regarding statistical
significance (Table 8).
In determining the clinical significance of utilizing
light therapy as an intervention to decrease
aggression, one study that utilized the Behavioral
Pathology in Alzheimer Disease Scale (BEHAVE-

AD) as an outcome measure found clinical
significance. Two studies found no clinical
significance and one study did not provide
information regarding clinical significance nor
sufficient data for significance to be calculated by
reviewers (Table 8). The remaining study which
utilized both the GIP and SDAS-9 to estimate
aggression found no clinical significance among
the results of the GIP, and did not provide
information regarding clinical significance from the
results of the SDAS-9 (Table 8).
Confusion
Five out of the 16 included studies evaluated the
efficacy of light therapy as an intervention to treat
the sundowning symptoms of confusion. Three of
these studies provided level I evidence, and two
studies provided level IV evidence (Table 8). The
quality of evidence among the five identified
studies ranged from low to high. Two studies had
high quality evidence, two studies had moderate
quality evidence, and one study had low-quality
evidence (Table 8).
Within the five relevant studies, there were five
outcome measures utilized to evaluate confusion
(Table 8). One study which utilized the GIP as an
outcome measure, found light therapy to be
effective in decreasing confusion (p<0.05; Table
8). Three studies found no statistical significance,
and one study, which utilized the CRS to estimate
confusion did not provide information regarding
statistical significance (Table 8). In regards to
clinical significance, two studies found light therapy
to have clinically significant results in treating
symptoms of confusion, while three studies did not
(Table 8).

PRACTICE RECOMMENDATIONS
Agitation
There were 15 studies that met this systematic
review inclusion criteria addressed the
effectiveness of light therapy in the treatment of
agitation. The level of evidence ranged from Level
I to level III, with a preponderance of level I
studies. Using a modified Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) system, this outcome
demonstrated low quality due to many of the
studies yielding mixed results regarding clinical

and statistical significance. As well as the
individual studies having low quality of evidence
regardless of level of evidence. Further research
will most likely impact the reviewers’ confidence in
the estimate of effect and more organized and
structured study designs with larger study
populations are suggested for more evidence.
(Guyatt et al, 2011).
Aggression
Five studies analyzed in this systematic review
addressed the use of light therapy in reducing
sundowning symptoms, specifically aggression.
The level of evidence ranged from level I to level III
with a preponderance of level III studies. Using a
modified GRADES classification system, this
outcome demonstrated low quality because only
one of the six studies resulted in high quality of
evidence (Guyatt et al, 2011). This indicates that
further research will most likely impact confidence
in the estimate of effect. Higher level studies with
better quality levels are suggested in order to
increase the validity and reliability of research
evidence (Guyatt et al, 2011).
Confusion
Five of the 16 studies analyzed in this systematic
review addressed the use of light therapy in
reducing the sundowning symptoms related to
confusion. A preponderance of these studies were
RCTs, which are considered level I evidence.
However, due to discrepancies in both the levels of
quality of evidence and the clinical and statistical
significance results, this outcome is considered of
moderate quality based on the GRADES
classification system (Guyatt et al, 2011). Further
research is likely to have an impact on confidence
in the estimate of effect. Rigorous study methods
and designs are suggested for future studies with
the expectation that improved research validity is
produced.

CLINICAL IMPLICATIONS
The 16 included studies in this systematic review
evaluated the efficacy of light therapy on
sundowning symptoms in individuals with
dementia. The three outcomes addressed—
agitation, aggression, and confusion—were
considered to have low and moderate quality
based on the GRADES classification system
(Guyatt et al, 2011).

Confusion was considered to have a moderate
quality designation from the modified GRADES
system which suggests that further research is
necessary and may impact clinical understanding
of light therapy and its effect on sundowning
symptoms in the future. However, agitation and
aggression were both found to have low-quality
based on the GRADES classification system,
which suggests that further research is necessary
and will impact clinical understanding of light
therapy and its effect on sundowning symptoms in
the future.
This systematic review shows that currently, the
preponderance of evidence provided in these
studies had moderate to low clinical significance
and p-values that demonstrated low statistical
significance. The benefits of utilizing light therapy
as an intervention to reduce sundowning
symptoms are unclear. Clinicians must analyze
each case, taking into consideration the cost and
burden of specialized lighting equipment, as well
as the lengthy administration time and supervision
needed for the intervention. Although study
limitations exist, utilizing bright light therapy to treat
sundowning symptoms is an option that would be
weakly recommended when addressing
aggression, agitation, and confusion in individuals
with dementia. This is due to the low to moderate
clinical significance of the three outcomes
analyzed. The significance of the outcomes were
further limited by multiple lower level studies and
limited sample sizes. Therefore, it is suggested
that clinicians discuss the potential risks and
benefits, as well as the unknown effectiveness,
with clients and their families before implementing
this intervention.
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Table 1
PICO question
PIndividuals with
dementia

ILight therapy

C* no comparison
needed

O–
Decreased
sundowning
behaviors

Table 2. List of the Databases to be Searched:
Databases Included in SR
Search

Planned the Search

Will conduct the Search

Person 1

Person 2

Person 1

Person 2

PubMed

group

group

Amanda

Christine

Cinahl

Alyssa

Amanda

Christine

Vivian

PsychINFO

Christine

Erica

Elise

Amanda

OT Seeker

Vivian

Erica

Alyssa

Amanda

OT Search

Alyssa

Amanda

Christine

Elise

Health and Medical Complete

Vivian

Elise

Erica

Alyssa

Cochrane

Elise

Christine

Vivian

Erica

Table 3. List of Search Terms:
Construct 1

Construct 2

Database

Subject
Headings

Keywords

Subject
Headings

Keywords

Health and
Medical
Complete
(ProQuest
Thesaurus,
NOT MeSH)

Dementia

Dementia (all
subjects &
indexing-SU),
“neurocogniti
ve dis*” (all
subjects &
indexing-SU),
Alzheimer*
(all subjects
& indexingSU)

Light therapy

Phototherapy
, light
therap*, light
treatment

A cross
search was
run using
keywords in
all fields vs
keywords in
SU and the
remaining
results were
irrelevant
PsycINFO

Dementia

Dementia,
Alzheimer*,
“Neurocogniti
ve Dis*”

Limits (if
any)

*light
treatment
has to be
utilized as a
keyword for
this database
as it retrieves
relevant
results that
are not
included
when
searched
without it

Phototherapy Phototherapy
, “Light
therap*”,
“light
treatment”not included
as it did not
effect
relevant

Subject
headings
found in apa
thesaurus

search
results
CINAHL

Dementia
[MeSH] OR
“neurocogniti
ve disease
[MeSH]”

Dementia OR
“Neurocogniti
ve dis”

Phototherapy “Light
[MeSH]
Therap*” OR
“Phototherap
*”

OT Seeker

**no subject
headings
recognized

“Neurodegen
erative dis*”
Alzheimer’s
Dementia

**no subject
headings
recognized

“Light
therap*”
***Tried
phototherapy
, came up
with 3 results,
2 of which
were same
as light
therapy, one
was
irrelevant.

*This site
does not
utilize
subject
headings*

Phototherapy
OR light
therapy

Not
necessary
to include
subject
heading as
keyword
search
returns only
4 results (1
relevant)

“Light
therapy” OR
phototherapy

**degenerative
vs. -cognitive.
-cognitive
yields 0
results.
OT Search

*This site
does not
utilize
subject
headings*

Dementia,
Alzheimer,
neurocognitiv
e disease

Cochrane

Not
necessary
to include
subject
heading as
keyword
search
returns only
4 results (1
relevant)

Dementia OR
“neurocogniti
ve disorder”

PubMed

Dementia

Dementia,
Phototherapy Phototherapy
Neurocognitiv
, light therap*

*This site
does not
recognize
truncation*

e disorder,
Alzheimer*
Note:
● Cochrane Library: Use search category “title, abstract, keywords”

Table 4. Boolean Sentence for each database:
Database Name

Boolean Sentence

PsycINFO

(IndexTermsFilt: "Phototherapy" OR Any Field: phototherapy OR Any
Field: ("light therap*"))AND (IndexTermsFilt: "Dementia" OR Any Field:
dementia OR Any Field: alzheimer* OR Any Field: ("neurocognitive
dis*"))

Health and
Medical
Complete

MAINSUBJECT.EXACT("Dementia") OR su("neurocognitive dis*")
OR su(dementia) OR su("alzheimer*") AND
(MAINSUBJECT.EXACT("Light therap*") OR Phototherapy OR
“Light therapy” OR “Light treatment”)

CINAHL

(“Dementia [MeSH]” OR “Dementia*” OR “Neurocognitive disease
[MeSH]” OR “Neurocognitive dis*”) AND (“Phototherapy [MeSH]”
OR “Phototherapy*” OR “Light therap**”)

OT Seeker

(Alzheimer’s OR dementia) AND (“Light therapy”) ***Tried
phototherapy, came up with 3 results, 2 of which were same as
light therapy, one was irrelevant.***

OT Search
(POWER
SEARCH)

("Dementia" OR "Alzheimer" OR "neurocognitive disease") AND
("light therapy" OR "phototherapy")

Cochrane

(Dementia OR “neurocognitive disorder”) AND (“Light therapy”
OR Phototherapy)

PubMed

(“Dementia” [Mesh] OR Dementia OR “Neurocognitive disorder”
OR Alzheimer*) AND (“Phototherapy” [Mesh] OR “light therap*” OR
phototherapy)

Table 5. Article inclusion and Exclusion Criteria
Inclusion Criteria
Population

Intervention and
Comparison

Outcome

Other

Dementia

Light therapy
(The treatment of
medical or psychiatric
conditions by the
controlled application
of light.)

Sundowning behavior

Peer Reviewed
English
Quantitative studies

Any type of
dementia

Must have at least 1
of 3 characteristics of
sundowning
(agitation, confusion,
and aggression)

All races,
ethnicities, genders,
socioeconomic
statuses
Any stage of
dementia
Exclusion Criteria
Population

Intervention and
Comparison

Not memory loss
due to other
conditions ex. TBI or
seizures

Not color therapy

Not heliotherapy
Not wave therapy
Not low-level light
therapy

Outcome

Other

(Defined as Low-level
laser therapy is a
form of alternative
medicine that applies
low-level lasers or
light-emitting diodes
to the surface of or in
orifices of the body)

Table 6. Quality of Evidence Worksheet
Quality Criteria

Citation

Type
of
design

1

2

3

4

5

6

7

8

9

10

Quality
Level

Evidence
Level

0

1

1

0

0

0

0

1

0

Moderate

1

n/a

n/a

Ancoli et al.,
2003

3

1

Barrick, A. L.,
et al., 2010

6

0

Burns et al.
2009

3

1

0

1

1

1

1

1

1

1

0

High

1

Dowling, Graf,
Hubbard, &
Luxenberg,
2007

3

1

0

1

1

0

1

0

1

1

1

High

1

Figueiro et al.,
2014

6

0

1

0

0

1

0

0

0

n/a

n/a

Low

3

Haffmans et
al., 2001

3

0

0

1

1

0

1

0

1

0

Moderate

1

Lovell et al.,
1995

7

1

1

1

1

0

1

1

1

n/a

n/a

High

4

Lyketsos et
al., 1999

3

0

0

1

1

1

0

0

0

1

0

Munch et al.,
2017

5

0

1

1

0

0

0

1

1

0

1

Moderate

2

Onega, Pierce
& Epperly,
2016

3

0

0

0

1

1

0

1

1

1

0

Moderate

1

Riemersma et
al., 2008

3

1

1

0

1

1

1

1

1

0

0

High

1

Satlin, et al,
1992

6

0

1

0

0

0

0

1

0

n/a

n/a

Low

3

1

1

0

0

1

0

1

3
Moderate

0

1
Moderate

Schindler, et
al, 2002

7

0

1

0

0

0

0

0

1

n/a

n/a

Low

4

Skjerve et al.,
2004

6

0

1

0

0

1

1

0

0

n/a

n/a

Low

3

Thorpe et al.,
2000

6

0

0

0

0

1

1

0

0

n/a

n/a

Low

3

Wahnschaffe
et al., 2017

7

1

1

1

0

0

0

1

n/a

n/a

Moderate

4

0

Table 7. Study Description Table

Table 8. Results Summary
# of
Articl
es

Level of
Evidenc
e

Quality of
Evidence

Outcome
Measures

Statistical
Significance

Clinical
Significance

1 S. (6)
N.S (3)
2. S. (2)
3. N.S (1)
4. S. (1)
5. N.S.(1)
6. S. (1)
7. Not Provided
8. S. (1)
9. S. (1)
10. Not Provided

1. S. (3)
N.S.(6)
2. N.S (2)
3. N.S. (1)
4. N.S.(1)
5. N.S. (1)
6. Not Calculable
7. N.S (1)
8. N.S. (1)
9. N.S. (1)
10. Not Calculable

Agitation
15

I - IV

Low: 5
Moderate: 6
High: 4

1.CMAI (9)
2.ABRS (2)
3. CRBRS (1)
4. NPI-NH (1)
5. BEHAVE-AD (1)
6. CADS (1)
7. CRS (1)
8. BARS (1)
9. PAS (1)
10.Observation (1)

Aggression
5

I-III

Low: 3
Moderate: 1
High: 1

1. NPI-NH (1)
2. GIP (1)
3. SDAS-9 (1)
4. BEHAVE-AD (1)
5. EBIC (1)
6.. Observation (1)

1 S. (1)
2. S. (1)
3. N.S. (1)
4. S. (1)
5. S. (1)
6.. Not Provided

1.N.S.(1)
2. N.S. (1)
3. Not Calculable
4. S. (1)
5. N.S. (1)
6. Not Calculable

Confusion
5

I-IV

Low: 1
Moderate: 2
High: 2

1.GIP (1)
2. S-MMSE (1)
3. NPI-Q (1)
4.CRS (1)
5. MOUSEPAD (1)

KEY:
S= SIGNIFICANT
N.S= NOT SIGNIFICANT
OUTCOME MEASURES:
ABRS: Agitated Behavior Rating Scale
BARS: Brief Agitation Rating Scale
Behave-AD: Behavioral Pathology in Alzheimer Disease scale
CADS: Change in Advanced Dementia Score
CMAI: Cohen-Mansfield Agitation Inventory
CRBRS: Crichton Royal Behavior Rating Scale

1.S.(1)
2. N.S. (1)
3. N.S. (1)
4. Not Provided
5. N.S. (1)

1.N.S. (1)
2. S. (1)
3. S. (1)
4. N.S. (1)
5. N.S.

CRS: Confusion Rating Scale
CS: Clinically Significant
EBIC: Environment-Behavior Interaction Cod
GIP: Gedragsobservatieschaal voor Intramurale Psychogeriatrie (Dutch version of the geriatric
behavioural observation scale)
MOUSEPAD: Manchester and Oxford Universities Scale for the Psychopathological Assessment of
Dementia
NPI-NH: Neuropsychiatric Inventory-Nursing Home
PAS: Pittsburgh Agitation Scale
SDAS-9: Social Dysfunction and Aggression Scale
S-MMSE: Severe Mini Mental Status Evaluation

Figure 1. Flowchart
Number of studies identified
through database search = 701
PsychINFO: 108
OT Search: 4
OT Seeker: 7
CINAHL: 102
Health & Medical Complete: 302
Cochrane: 4
Pubmed: 174

Number of studies excluded after
screening “Title and Abstract”= 662
Causes of Exclusion:
Not peer reviewed: 24
Not published in English: 2
Not Quantitative Study: 133
Systematic Review: 21
Population not individuals with
dementia: 69
Intervention is not “light therapy”
(as defined by reviewers): 203
Outcome does not include
decreasing “sundowning” behavior
(as defined by reviewers): 211

Duplicates Removed: 22

Number of articles included in
Systematic Review: 17

1 article unable to be retrieved

Total Number of Remaining Articles: 39

Number of articles included in
Systematic Review: 16

